Pulse Biosciences is a medical technology company developing a proprietary therapeutic tissue treatment platform based on Nano-Pulse Stimulation (NPS), a non-thermal, precise, focal drug-free tissue treatment technology. NPS technology delivers nano-second pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue. The Company's CellFX System, powered by NPS technology, is designed to clear unwanted cellular lesions in a broad range of dermatologic conditions. The Company is pursuing a multi-application platform through internal development and collaborations with strategic partners. The Company believes its NPS technology may play a role in immune oncology as a focal tumor treatment as well as in nerve regeneration, and in treating wound healing disorders.